Search

everythinglearnresearchcommunity

for

Search:↓

Treat pattern hair loss with finasteride and topical minoxidil.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Finasteride negatively affects fish reproduction and gonadal development.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Low testosterone may increase COVID-19 severity in men.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Purple corn extract may help reduce prostate enlargement and inflammation.

Hair loss linked to kidney stones in people under 60.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

A gene called HDAC9 might be a new factor in male-pattern baldness.